Literature DB >> 2942341

Cardiovascular adaptation to obesity and hypertension.

C J Lavie, F H Messerli.   

Abstract

Hypertension and obesity are two disorders that are closely related; each occurs more frequently with the other than in an otherwise normal population. These two disorders, however, exert disparate effects on cardiovascular structure and function. The hallmark of essential hypertension is an increased total peripheral resistance, and hypertensive patients have a contracted intravascular volume and normal cardiac output but an increased left ventricular stroke work due to a high afterload. In contrast, obese patients have an increased intravascular volume, left ventricular filling pressure, cardiac output and a lower total peripheral and renal vascular resistance. Left ventricular adaptation will consist of eccentric hypertrophy in obesity regardless of the level of arterial pressure and concentric hypertrophy in lean hypertensive patients. Although obesity may mitigate the harmful effect of a chronically elevated total peripheral and renal vascular resistance and lessen target organ damage in essential hypertension, the combination of obesity and hypertension presents a double burden to the left ventricle and is associated with systolic and diastolic dysfunction and a propensity for high grade ventricular dysrhythmias. It is not surprising that congestive heart failure and sudden death are common sequelae of obesity hypertension. Weight reduction reduces arterial pressure by decreasing intravascular volume and cardiac output associated with a fall in sympathetic activity and reversal of cardiac hypertrophy. Therefore, weight loss unloads the heart from the two-fold burden caused by obesity and hypertension and should become a major goal in the prevention and treatment of heart disease.

Entities:  

Mesh:

Year:  1986        PMID: 2942341     DOI: 10.1378/chest.90.2.275

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Pressure pulse contour-derived stroke volume and cardiac output in the morbidly obese patient.

Authors:  Donald P Bernstein
Journal:  Obes Surg       Date:  2008-04-29       Impact factor: 4.129

Review 3.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

4.  Impact of left ventricular geometry on prognosis-a review of ochsner studies.

Authors:  Carl J Lavie; Richard V Milani; Sangeeta B Shah; Yvonne E Gilliland; Jose A Bernal; Homeyar Dinshaw; Hector O Ventura
Journal:  Ochsner J       Date:  2008

Review 5.  Obesity and coronary microvascular disease - implications for adipose tissue-mediated remote inflammatory response.

Authors:  Zsolt Bagi; Zuzana Broskova; Attila Feher
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

6.  Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss.

Authors:  Surya M Artham; Carl J Lavie; Richard V Milani; Hector O Ventura
Journal:  Ochsner J       Date:  2009

Review 7.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Adiposity, but not Obesity, Is Associated With Arterial Stiffness in Young Nulliparous Women.

Authors:  Julie Phillips; Carole A McBride; Erin Morris; Abigail M Crocker; Ira Bernstein
Journal:  Reprod Sci       Date:  2017-09-01       Impact factor: 3.060

Review 9.  Overfeeding, autonomic regulation and metabolic consequences.

Authors:  A J Scheurink; B Balkan; J H Strubbe; G van Dijk; A B Steffens
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

10.  Plasma turnover of 3,4-didehydroretinol (vitamin A2) increases in vitamin A-deficient rats fed low versus high dietary fat.

Authors:  Anne L Escaron; Michael H Green; Sherry A Tanumihardjo
Journal:  J Lipid Res       Date:  2008-11-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.